Tag: BMY

  • Weakness in Bristol Myers Squibb is a Big Opportunity

    Weakness in Bristol Myers Squibb is a Big Opportunity

    Bristol Myers Squibb (BMY) is on the move. After plummeting from about $68 to a low of $54.60, the oversold stock is just starting to pivot higher.  In fact, from a current price of $58.65, we’d like to see the stock retest $68. Helping, the company just boosted its quarterly dividend to 54 cents a…